公司近况4 月22 日晚,公司公告建议分拆子公司德镁医药于港交所主板独立上市,分拆建议仍需取决于相关部门批准、公司董事会以及德镁医药董事会批准。评论拟采用介绍上市方式,原股东权益不会被稀释。根据公告,建议分拆(若进行)采用实物方式向股东分派其持有所有德镁医药股份方式实施,股东享有的德镁医药股权不会被稀释。目前德镁医药90.8%股权由康哲药业持有,9.2%股权由两个员工激励平台持有。分拆完成上市后,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.